Synthesis and Evaluation of Vitamin D3 Analogues with C-11 Modifications As Inhibitors of Hedgehog Signaling
Overview
Authors
Affiliations
Previous structure-activity relationship studies have provided potent and selective analogues of vitamin D3 as inhibitors of the Hedgehog (Hh) signaling pathway. These analogues contain both modified A- and seco-B ring motifs, and have been evaluated for anticancer therapeutic potential. To continue our studies on this scaffold, a new series of compounds were synthesized to explore additional interactions and spatial constraints. These compounds incorporate functional groups of varying size and hydrophobicity at the C-11 position. While large hydrophobic moieties (9c-e) resulted in significant loss of Hh inhibition, smaller or more flexible moieties (9a, 11) maintain anti-Hh activity. These results call for additional and continued studies to identify the binding pocket to better understand these structure-activity relationships.
Chen W, Lai F, Xu J Int J Mol Sci. 2025; 26(4).
PMID: 40004093 PMC: 11855207. DOI: 10.3390/ijms26041631.
Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances.
Ma C, Hu K, Ullah I, Zheng Q, Zhang N, Sun Z Front Oncol. 2022; 12:729088.
PMID: 35433472 PMC: 9010822. DOI: 10.3389/fonc.2022.729088.
Design of Hedgehog pathway inhibitors for cancer treatment.
Bariwal J, Kumar V, Dong Y, Mahato R Med Res Rev. 2018; 39(3):1137-1204.
PMID: 30484872 PMC: 6714585. DOI: 10.1002/med.21555.